MENU
IMAB
AS OF
Oct 29 closing price
Price
$4.63
Change
-$0.01 (-0.22%)
Capitalization
534.83M
Intraday BUY SELL Signals
IMAB
Stock ticker: NASDAQ
AS OF
Oct 29 closing price
Price
$4.63
Change
-$0.01 (-0.22%)
Capitalization
534.83M
IMAB stock forecast, quote, news & analysis
I-MAB is a clinical-stage biotech company... Show more
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I.Advisor
a Summary for IMAB with price predictions
Nov 03, 2025
IMAB sees its Stochastic Oscillator recovers from oversold territory
On November 03, 2025, the Stochastic Oscillator for IMAB moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 69 instances where the indicator left the oversold zone. In of the 69 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Technical Analysis (Indicators)
Bullish Trend Analysis
Bearish Trend Analysis
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com